Separation of WAP-8294A components, a novel anti-methicillin-resistant Staphylococcus aureus antibiotic, using high-speed counter-current chromatography

Citation
K. Harada et al., Separation of WAP-8294A components, a novel anti-methicillin-resistant Staphylococcus aureus antibiotic, using high-speed counter-current chromatography, J CHROMAT A, 932(1-2), 2001, pp. 75-81
Citations number
18
Categorie Soggetti
Chemistry & Analysis","Spectroscopy /Instrumentation/Analytical Sciences
Journal title
Volume
932
Issue
1-2
Year of publication
2001
Pages
75 - 81
Database
ISI
SICI code
Abstract
The WAP-8294A complex was isolated from the fermentation broth of Lysobacte r sp. WAP-8294, whose major component, WAP-8294A2, showed a strong activity against Grain-positive bacteria including methicillin-resistant Staphyloco ccus aureus (MRSA) and vancomycin-resistant Enterococci in vitro, and also exhibited a potent activity against MRSA in vivo, The previous separation p rocedure using the conventional chromatographic methods was laborious and t ime-consuming, and the recovery of the desired compound was often unsatisfa ctory. In the present study, high-speed counter-current chromatography (HSC CC) was applied to the separation of the main components of the WAP-8294A c omplex. Due to the high polarity of the target compounds, we selected a hyd rophilic two-phase solvent system composed of n-butanol-ethyl acetate-aqueo us 0.005 M trifluoroacetic acid (1.25:3.75:5, v/v/v) which provided a suita ble range of partition coefficient values for these compounds, Although the settling time of this solvent system was much longer than the optimum rang e, suggesting a low retention of the stationary phase under the standard ex perimental conditions, the separation was successfully performed at the low flow-rate of 0.5 ml/min. A sample size of 25 mg yielded pure fractions of three components (1-6 mg). The identification of each component was carried out by HPLC and fast atom bombardment mass spectrometry. The method will c ontribute to the clinical development of WAP-8294A2 as an anti-MRSA agent. (C) 2001 Elsevier Science B.V. All rights reserved.